Clastogenic factors: Biomarkers of oxidative stress of potential utility in the clinical chemistry laboratory

Annals of Clinical and Laboratory Science

Volumn 29, Issue 2, 1999, Pages 134-139

  Liu, Tsan Zon ^a   Stern, Arnold ^b   Emerit, Ingrid ^c  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN;

ARTICLE; CHRONIC INFLAMMATION; DIAGNOSTIC VALUE; GENETIC DISORDER; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRRADIATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SCLERODERMA;

BIOLOGICAL MARKERS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MUTAGENS; OXIDATIVE STRESS;

HUMAN IMMUNODEFICIENCY VIRUS; SCLERODERMA;

EID: 0032952837     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Goh KO, Summer K. Breaks in normal human chromosomes; are they induced by a transferable substance in the plasma of irradiated persons exposed to total-body irradiation? Radiation Res 1968;6:51-60.
2. Hollowell HG, Littlefield LG. Chromosome damage induced by plasma from irradiated patients. An indirect effect of X-ray. Proc Soc Exp Biol Med 1968;129: 240-4.
3. Faguet GG, Reichard SM, Welter DA. Radiation-induced clastogenic plasma factors. Cancer Genet Cytogenet 1984;12:73-83.
4. Emerit I. Reactive oxygen species, chromosome mutation and cancer: role of clastogenic factors in carcinogenesis. Free Radic Biol Med 1994;16:99-109.
5. Emerit I. Membrane-mediated chromosome damage and formation of clastogenic factors in: Membrane Lipid Oxidation (C. Vigo-Pelfrey, ed.). Boca Raton: CRC Press, 1991:33-43.
6. Auclair C, Gouyette A, Levy A, Emerit I. Clastogenic inosine nucleotides as components of the chromosome breakage factor in scleroderma patients. Arch Biochem Biophys 1990;278:238-44.
7. Roselli F, Sanceau J, Gluckman E, et al. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 1994;83:1216-25.
8. Emerit I, Autoreri A, Auclair C, Levy A, et al. Role of oxygen free radicals in progressive systemic sclerosis (scleroderma). In: Hayaishi O, et al. eds. Medical, biochemical and chemical aspects of free radicals. Amsterdam: Elsevier Sceince, 1989:1211-18.
9. Emerit I, Fabiani JN, Levy A, Ponzio O, et al. Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes. Free Radic Biol Med 1995;19:405-15.
10. Emerit I, Khan SH, Cerutti P. Treatment of lymphocyte cultures with a hypoxanthine-xanthine oxidase system induces the formation of transferable clastogenic material. Free Radic Biol Med 1985;1:51-7.
11. Emerit I, Cerutti P. Clastogenic activity from Bloom's syndrome fibroblast cultures. Proc Natl Acad Sci USA 1981;78:1868-72.
12. Emerit I, Cerutti P. Tumor promoter phorbolmyristate acetate induces a clastogenic factor in human lymphocytes. Proc Natl Acacl Sci USA 1982; 79:7509-13.
13. Emerit I, Garban F, Vassy J, Levy A, et al. Superoxide-mediated clastogenic and anticlastogenic effects of exogenous superoxide dismutase. Proc Natl Acad Sci USA 1996;93:12799-805.
14. Pogrebniak HW, Matthews WA, Pass HI. Reactive oxygen species can amplify macrophage tumor necrosis factor production. Surg Forum 1990;XVI:101-5.
15. 2 generation. Lab Invest 1988;58:448-53.
16. Witz G, Lawrie NJ, Amoruso MA, Goldstein BD. Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Biochem Pharmacol 1987;36:721-26.
17. Wavra E, Zollner H, Schaur RJ, Tillian HM, et al. The inhibitory effect of 4-hydroxynonenal on DNA polymerases alpha and beta from rat liver and rapidly dividing Yoshida ascites hepatoma. Cell Biochem Function 1986;4:31-6.
18. Emerit I, Levy A, Michelson AM. Effect of superoxide dismutase on the chromosomal instability of NZB mice. Cytogenet Cell Genet 1981;30:65-9.
19. Emerit I, Feingold J, Levy A, Martin E, et al. Tumor incidence and development of autoimmune hemolytic anemia in two breeding lines of the NZB mouse strain that differ in chromosome breakage. JNCI 1980;64: 513-7.
20. Khan SH, Emerit I, Feingold J. Superoxide and hydrogen peroxide production by macrophages of NZB mice. Free Radic Biol Med 1990;8:339-45.
21. Camus JP, Emerit I, Michelson AM, Prier A, et al. Superoxide dismutase et polyarthrite rhumatoide. Revue du Rheumatism 1980;47:489-92.
22. Emerit I, Michelson AM. Chromosomal breakage in Crohn's disease. In: Pena AS, Weterman IT, Booth CC, Storber W, eds. Recent Advances in Crohn's Disease. The Hague: Martinus Nijhoff Publishers, 1981: 225-9.
23. Fuchs J, Emerit I. Clastogenic factors in plasma of HIV-infected patients. Free Radic Biol Med 1995;19: 843-8.
24. Edeas MA, Emerit I, Khalfoun Y, Lazizi Y, et al. Clastogenic factors in plasma of HIV-infected patients activate HIV-1 replication in vitro. Inhibition by superoxide dismutase. Free Radic Biol Med 1997;23: 571-8.
25. Emerit I, Oganesian N, Sarkisian T, Aroutiounian R, et al. Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Ginkgo biloba extract. Radiation Res 1995;144:198-205.
26. Emerit I, Oganesian N, Aroutiounian R, Pogossian A, et al. Oxidative stress-related clastogenic factors in plasma from Chernobyl liquidators: protective effects of antioxidant plant phenols, vitamins and oligoelements. Mutat Res 1997;377:239-46.
27. Emerit I. Clastogenic factors: detection and assay. In: Packer L, Glazer AN, eds. Methods in Enzymology. New York: Academic Press, 1990:555-64.
28. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, 1998 3rd ed. Oxford: Clarendon Press.
29. Pant GS, Kamada N. Chromosome aberrations in normal human leukocytes induced by the plasma of exposed individuals. Hiroshima J Med Sci 1977;26: 149-54.
30. Emerit I, Levy A, Cernjavski L, Aroutiounian R, et al. Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor. J Cancer Res Clin Oncol 1994;120:558-61.
31. Emerit I, Quastel M, Goldsmith J, Merkin L, et al. Clastogenic factors in the plasma of children exposed at Chernobyl. Mutat Res 1997;373:47-54.
32. Alaoui-Youssefi A, Arontiounian R, Emerit I. Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors. Mutat Res 1994;309:185-91.
33. Filipe P, Emerit I, Alaoui-Youssefi A, Levy A, et al. Oxyradical-mediated clastogenic plasma factors in psoriasis. Increase in clastogenic activity after PUVA. Photochem Photobiol 1997;66:497-501.
34. Emerit I, Michelson AM. Mechanisms of photosensitivity in systemic lupus erythematosus patients. Proc Natl Acad Sci USA 1981;8:2537-40.
35. Emerit I, Emerit J, Tosoni-Pittoni A, Bousquet O, et al. Chromosome studies in patients with ulcerative colitis. Hum Genet 1972;216:313-22.
36. Emerit I, Filipe P, Meunier P, Auclair C, et al. Clastogenic factors in plasma of scleroderma patients: a biomarker of oxidative stress. Dermatology 1997;194: 140-6.
37. Emerit I, Levy A, Camus JP. Monocyte-derived clastogenic factor in rheumatoid arthritis. Free Radic Biol Med 1989;6:245-50.
38. Emerit I. Clastogenic factors as biomarkers of oxidative stress. In: Ozben T, ed. Free Radicals, Oxidative Stress and Antioxidants. New York: Plenum Press 1998:375-83.
39. Serejo F, Filipe P, Emerit I, Freitas J, et al. Biomarkers of oxidative stress in patients with chronic hepatitis C. J Hepatology 1998, Suppl. 1, Vol. 28.
40. Emerit I, Aroutiounian R, Sarkisian T, Torossian E, Panossian AG. Oxyradical-related chromosome damage in patients with Familial Mediterranean Fever. Free Radic Biol Med 1993;15:265-71.
41. Shaham M, Becker Y. The ataxia telangiectasia clastogenic factor is a low molecular weight peptide. Hum Genet 1986;75:197-208.
42. Emerit I, Levy A, Pagano G, Pinto L, et al. Transferable clastogenic activity in plasma from patients with Fanconi anemia. Hum Genet 1995;96:14-20.